| Paraoxonase-1 Q192R polymorphism is not associated with clopidogrel response in Chinese stroke patients. | |
| | |
MedLine Citation:
|
PMID: 23346768 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
It is well known that CYP2C19*2/*2 is associated with attenuated response to clopidogrel, but recent findings indicated that in white patients, paraoxonase-1 (PON1) 192Q/Q was a major determinant of clopidogrel efficacy. The objective of this research was to assess the impact of PON1 Q192R polymorphism on the maximum platelet aggregation (MPA) and the anti-platelet effect of clopidogrel in clopidogrel-treated Chinese stroke patients. The study recruited 183 eligible Chinese stroke patients treated with a loading dose of 300-mg clopidogrel and a 75-mg daily maintenance dose. CYP2C19*2 and PON1 Q192R were genotyped, a subcohort of 13 patients with CYP2C19 *2/*2 genotype was excluded. Finally 170 patients with CYP2C19*1/*1 (wild-type homozygotes, n = 87) or CYP2C19*1/*2 (mutant heterozygotes, n = 83) were enrolled in the study population. These patients were divided into three groups according to their PON1 Q192R genotype: wild-type homozygotes, PON1 192QQ, n = 17; mutant heterozygotes, PON1 192QR, n = 81; mutant homozygotes, PON1 192RR, n = 72. MPA was measured by light transmittance aggregometry (LTA) to assess platelet function after seven 75-mg maintenance doses of clopidogrel before discharge. In those patients who were carriers of 1 mutant allele (PON1 Q/R192), ADP-induced MPA were not significantly different compared with wild-type homozygous patients [30.5% (IQR, 17.5 to 49.1%) versus 25.0% (IQR, 10.0 to 52.5%), respectively; P = 0.910]. In addition, in the patients who were carriers of the 2 mutant allele (PON1 R/R192), MPA were also not significantly different from wild-type homozygous patients [29.2% (IQR, 15.0 to 43.4%) versus 25.0% (IQR, 10.0 to 52.5%), respectively; P = 0.717]. Results of a multivariable linear regression model demonstrated that PON1 192R allele carriage was not independently associated with ADP-induced MPA measurements (P = 0.408). PON1 Q192R polymorphism does not seem to exhibit any impact on MPA and clopidogrel response at all. |
| | |
Authors:
|
Jie Yang; Jun-Shan Zhou; Jie Tan; Bang-Shun He; Jian-Jun Zou |
Related Documents
:
|
22954058 - Impedance baseline and reflux perception in responder and non-responder non-erosive ref... 23560988 - Clinical characteristics of collagenous colitis with linear ulcerations. 23135058 - Rheumatoid nodule presenting as morton's neuroma. 23100088 - Diagnosis and assessment of takayasu arteritis by multiple biomarkers. 21098408 - Head position during resting modifies spontaneous daytime decrease of downbeat nystagmus. 3910658 - Septic arthritis of the hip joint: sonographic and ct findings. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Die Pharmazie Volume: 67 ISSN: 0031-7144 ISO Abbreviation: Pharmazie Publication Date: 2012 Dec |
Date Detail:
|
Created Date: 2013-01-25 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9800766 Medline TA: Pharmazie Country: Germany |
Other Details:
|
Languages: eng Pagination: 1026-9 Citation Subset: IM |
Affiliation:
|
Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Examination of factors that delay the elution of acetaminophen from over-the-counter drugs.
Next Document: Clinical efficacy of two forms of intravenous iron--saccharated ferric oxide and cideferron--for iro...